Catalyst Repository | Akers Biosciences Inc. Common Stock

Akers Biosciences Inc. Common Stock

(NASDAQ:AKER)

Description

Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York.

AKER Overview

None
Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances

Previous Close
$3.0100
Previous Close Volume
530413